spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

Tag: AstraZeneca's fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry heats up

AstraZeneca’s fixed-duration Calquence combo wins FDA nod as BeOne CLL rivalry heats up

AstraZeneca has secured a key regulatory win in its effort to reclaim the lead in the BTK inhibitor market,...